Annual SGA
$7.43 M
-$403.10 K-5.15%
December 31, 2023
Summary
- As of March 10, 2025, INKT annual SGA is $7.43 million, with the most recent change of -$403.10 thousand (-5.15%) on December 31, 2023.
- During the last 3 years, INKT annual SGA has risen by +$6.14 million (+477.08%).
- INKT annual SGA is now -5.15% below its all-time high of $7.83 million, reached on December 31, 2022.
Performance
INKT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.16 M
+$101.20 K+9.53%
September 30, 2024
Summary
- As of March 10, 2025, INKT quarterly SGA is $1.16 million, with the most recent change of +$101.20 thousand (+9.53%) on September 30, 2024.
- Over the past year, INKT quarterly SGA has stayed the same.
- INKT quarterly SGA is now -50.77% below its all-time high of $2.36 million, reached on December 31, 2021.
Performance
INKT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$552.24 M
-$13.78 M-2.56%
September 30, 2024
Summary
- As of March 10, 2025, INKT TTM SGA is -$552.24 million, with the most recent change of -$13.78 million (-2.56%) on September 30, 2024.
- Over the past year, INKT TTM SGA has dropped by -$557.93 million (-9797.40%).
- INKT TTM SGA is now -947.19% below its all-time high of -$52.74 million.
Performance
INKT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
INKT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.2% | 0.0% | -9797.4% |
| 3 y3 years | +477.1% | 0.0% | -9797.4% |
| 5 y5 years | +94.1% | 0.0% | -9797.4% |
INKT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.2% | +60.2% | -50.8% | +9.5% | -147.6% | at low |
| 5 y | 5-year | -5.2% | +477.1% | -50.8% | +477.1% | -947.2% | at low |
| alltime | all time | -5.2% | +477.1% | -50.8% | +477.1% | -947.2% | at low |
MiNK Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.16 M(+9.5%) | $5.69 M(-10.0%) |
| Jun 2024 | - | $1.06 M(-17.1%) | $6.33 M(-10.3%) |
| Mar 2024 | - | $1.28 M(-41.5%) | $7.05 M(-5.1%) |
| Dec 2023 | $7.43 M(-5.1%) | $2.19 M(+21.9%) | $7.43 M(+1.5%) |
| Sep 2023 | - | $1.80 M(+0.6%) | $7.32 M(-0.6%) |
| Jun 2023 | - | $1.78 M(+7.5%) | $7.36 M(-0.5%) |
| Mar 2023 | - | $1.66 M(-20.1%) | $7.40 M(-5.6%) |
| Dec 2022 | $7.83 M | $2.08 M(+13.0%) | $7.83 M(-3.5%) |
| Sep 2022 | - | $1.84 M(+0.8%) | $8.12 M(+14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $1.82 M(-13.1%) | $7.10 M(+15.5%) |
| Mar 2022 | - | $2.10 M(-11.2%) | $6.14 M(+32.4%) |
| Dec 2021 | $4.64 M(+260.3%) | $2.36 M(+189.9%) | $4.64 M(+135.6%) |
| Sep 2021 | - | $814.90 K(-6.1%) | $1.97 M(+21.5%) |
| Jun 2021 | - | $867.90 K(+45.9%) | $1.62 M(+115.2%) |
| Mar 2021 | - | $595.00 K(-292.9%) | $753.50 K(+375.4%) |
| Dec 2020 | $1.29 M(-66.4%) | -$308.40 K(-166.1%) | $158.50 K(-66.1%) |
| Sep 2020 | - | $466.90 K | $466.90 K |
| Dec 2019 | $3.83 M | - | - |
FAQ
- What is MiNK Therapeutics annual SGA?
- What is the all time high annual SGA for MiNK Therapeutics?
- What is MiNK Therapeutics annual SGA year-on-year change?
- What is MiNK Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly SGA year-on-year change?
- What is MiNK Therapeutics TTM SGA?
- What is the all time high TTM SGA for MiNK Therapeutics?
- What is MiNK Therapeutics TTM SGA year-on-year change?
What is MiNK Therapeutics annual SGA?
The current annual SGA of INKT is $7.43 M
What is the all time high annual SGA for MiNK Therapeutics?
MiNK Therapeutics all-time high annual SGA is $7.83 M
What is MiNK Therapeutics annual SGA year-on-year change?
Over the past year, INKT annual SGA has changed by -$403.10 K (-5.15%)
What is MiNK Therapeutics quarterly SGA?
The current quarterly SGA of INKT is $1.16 M
What is the all time high quarterly SGA for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly SGA is $2.36 M
What is MiNK Therapeutics quarterly SGA year-on-year change?
Over the past year, INKT quarterly SGA has changed by $0.00 (0.00%)
What is MiNK Therapeutics TTM SGA?
The current TTM SGA of INKT is -$552.24 M
What is the all time high TTM SGA for MiNK Therapeutics?
MiNK Therapeutics all-time high TTM SGA is -$52.74 M
What is MiNK Therapeutics TTM SGA year-on-year change?
Over the past year, INKT TTM SGA has changed by -$557.93 M (-9797.40%)